MAPK1 and melanoma: Consistent with these findings, our lab reported the unique feature of ACA-28 to induce apoptosis preferentially in ERK-active cancer cells, including melanoma cell lines (SK-MEL-28, SK-MEL-2, and MeWO) or HER2-overexpressing cells, but not in normal melanocyte or NIH/3T3 cells, respectively.